Background
Due to previous surgical history and subsequent adhesions between pelvic organs, surgery for cervical stump cancer (CSC) is technically more challenging than surgery for cervical cancer with an intact uterus.1 We aimed to illustrate the related anatomy, surgical steps and techniques of complete laparoscopic type C2 radical surgery (CLRS) for early-stage CSC.
Methods
CLRS for six patients with CSC was performed from January 2021 to January 2022. We demonstrated the detailed skills of parametrial management during CLRS for CSC in case 5 by means of a video. A 58-year-old woman diagnosed with International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIA1 CSC received CLRS through five operative ports (Fig. 1).
Results
The magnetic resonance imaging (MRI) scans and gross appearance of the specimen are shown in Fig. 2.The median age and body mass index (BMI) of the six patients were 53 years and 23.8, respectively. The median blood loss was 275 mL; the median time of operation was 218 min; the median length of hospitalization was 15 days; and the median time to recover urinary function was 12 days. One patient underwent postoperative radiation for pathologically proven adenocarcinoma with deep stromal invasion,2 while the other five did not. After a median follow-up of 24 months, no patients experienced complications, recurrence, or death (Table 1).
Conclusions
This study details the skills of CLRS for CSC, especially space development and the ‘no-look, no-touch’ tumor-free principle. It is helpful for clinicians to perform safe and standardized surgery on patients with early-stage CSC.
Table 1 Clinicopathological characteristics, operative details, and outcomes of patients with cervical stump cancer
Patient no.
Age at diagnosis (years)
BMI
Reasons for subtotal hysterectomy
FIGO 2018 stage
Histology
Operation
Operation time
(mins)
Blood loss (mL)
Urinary catheter (days)
Hospital stay (days)
Complications
Depth of invasion
LVSI
LNs dissected
TNM stage
Tumor size (mm)
Postoperative radiotherapy
Follow-up (months)
Recurrence
Death
1
50
25.9
Uterine
myoma
IIA1
ASC
CLRS+PLND
221
360
10
12
No
Middle one-third
N
13
T2a1N0M0
16
No
30
No
No
2
55
17.3
Uterine
myoma
IB1
AC
CLRS+PLND
191
270
20
12
No
Deep
one-third
N
24
T1b1N0M0
10
Yes
20
No
No
3
50
24.8
Uterine
myoma
IB1
SC
CLRS+PLND
295
310
13
15
No
Superficial one-third
N
21
T1b1N0M0
15
No
25
No
No
4
63
30.1
Uterine
myoma
IB1
SC
CLRS+PLND
213
180
6
16
No
Superficial one-third
N
25
T1b1N0M0
15
No
19
No
No
5
58
20.2
Postpartum hemorrhage
IIA1
SC
CLRS+PLND
220
100
11
14
No
Middle one-third
N
21
T2a1N0M0
15
No
24
No
No
6
46
22.7
Uterine
myoma
IB1
SC
CLRS+PLND
215
120
14
17
No
Superficial one-third
N
26
T1b1N0M0
12
No
23
No
No
BMI body mass index, FIGO International Federation of Gynecology and Obstetrics, ASC cervical adenosquamous carcinoma, AC cervical adenocarcinoma, SC cervical squamous carcinoma, CLRS+PLND complete laparoscopic radical surgery and pelvic node dissections, LVSI lymphovascular space invasion, N negative, LNs lymph nodes, TNM tumor node metastasis